Register for our S/EIS Fund

o2h discovery, a preclinical Contract Research Organization which has an integrated drug discovery platform, is pleased to announce the second edition of the o2h kickstarter competition 2.0 exclusively aimed towards supporting Australian early stage biotech companies. After the overwhelming response to the first competition, we are back with another edition to specifically support early stage Aus Biotech in their drug discovery programmes.

Aus Biotech has a globally competitive biotech ecosystem which has impact significantly higher than its size compared to the overall global Biotech sector. We at o2h discovery have recognised this powerhouse of research excellence and are dedicating a Kickstarter competition focused only on the Aus Biotech ecosystem.

The programme aims to extend o2h discovery’s small molecule and medicinal chemistry research expertise to seed early stage Aus biotech companies with breakthrough drug discovery programme and plans to advance them to the next milestone.


We understand that drug discovery research is a complex phenomenon. The first phase itself requires synthesis and screening of large numbers of new molecules to identify a “hit”. This initial phase we believe could be extremely time consuming as well as costly. The o2h kickstarter competition has been developed to provide a boost to small molecule focused biotech companies who need to supercharge their chemistry efforts to meet their next funding milestone.

o2h discovery believes in working collaboratively and would like to play our part by supporting promising drug discovery research. Although this is a time-limited competition, if supportive to the global biotech ecosystem we will run this again. 

The applications will be evaluated by the kickstarter committee including Sunil Shah, Co-founder of o2h group, Andy Morley, CSO of o2h discovery amongst others. The programme offers a dedicated team of six FTE chemists for each project, access to a large inventory of chemicals and reagents for synthesis in order to support small molecules research at reasonable costs. For more information and to apply, visit –

Sunil Shah, Co-founder of o2h discovery, said:

Very excited to launch this o2h kickstarter competition focused on Australian Biotech.  We have worked with several biotech companies over the years in Australia and we have seen some great science and successful companies created over the years.”

Andy, Chief Scientific Officer of o2h discovery, said:

“The o2h kickstarter programme will help provide cost effective resource for early stage projects to allow them to generate exploratory SAR and data to validate early concepts and support subsequent fund raising activities.”


Editor Notes:

About o2h discovery:

Founded in 2005, o2h discovery is a leading drug discovery partner and has capabilities to support hit-lead-optimisation programmes leading into patent and IND filing from our state-of-the-art research centre in Ahmedabad, India and The Mill SciTech Park, Cambridge, UK. We have the in-house capability to execute hit-lead-optimization programs leading into patent and IND filing from our state-of-the-art biotechnology incubator with expertise in discovery chemistry, biology, pharmacology, and the ongoing project management of pre-clinical development. 

o2h discovery has developed and launched its proprietary application Chemistry in the Cloud™ (CITC), the world’s first app to revolutionize the project management of external drug discovery programs. The app enables the communication between various scientific stakeholders essential to successful project advancement – leading to faster decision making. 

The DNA of o2h discovery is centered around the nurturing of its people, values, and culture. It reflects in the way we work with each other, as well as our collaborators and partners. 

For more information about o2h group, please visit and to know more about our chemistry services, please see –

About o2h Group:

o2h group seeds new ideas in science, technology and green innovation. We work across boundaries and take a collaborative and shared approach to innovation, and therefore we co-invest, co-create and co-execute to bring these ideas to life. o2h group triages investment, incubation and execution and is organized into 6 symbiotic verticals; o2h ventures, o2h discovery, o2h technology, o2h co-work, o2h therapeutics, and o2h community.

For more information, please see – 

Press Release – Curza and o2h discovery announce a multi-FTE chemistry collaboration against gram negative

recent blogs

Comments are closed.